VNS THERAPY SYSTEM
FDA premarket approval P970003/S115 · decided 2010-11-18
Approval details
- PMA number
- P970003
- Supplement
- S115
- Supplement type
- Real-Time Process
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- VNS THERAPY SYSTEM
- Generic name
- Stimulator, autonomic nerve, implanted for epilepsy
- Applicant
- LivaNova USA, Inc.
- Date received
- 2010-09-21
- Decision date
- 2010-11-18
- Days to decision
- 58 days
- Decision code
- APPR
- Product code
- LYJ
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Houston, TX
- Statement
- APPROVAL FOR CHANGES TO BATTERY LONGEVITY DESIGN REQUIREMENTS AND RELATED LABELING OF BATTERY LONGEVITY TABLES FOR YOUR MODEL 102 AND 102R PULSE GENERATORS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Venous Return Cannulae (K250937) | LivaNova USA, Inc. | 2026-03-11 |
| RAP Femoral Venous Cannulae (K250283) | LivaNova USA, Inc. | 2025-07-10 |
| SMARxT Tubing and Connectors (K233702) | LivaNova USA, Inc. | 2024-08-08 |